ICAAC 54th (2014)

Drupal spam blocked by CleanTalk.
Title Content type
Combination Aspf3, Aspf9 and Hemolysin Liposomal Vaccines Provide Protection Against Murine Pulmonary Aspergillus Challenge (click for details)
Isavuconazole is Effective for the Treatment of Experimental Cryptococcal Meningitis (click for details)
Antifungal and Anti-Pneumocystis Activity of the Novel Arylamidine T-2307 (click for details)
A Phase 3 Randomized, Double-Blind, Non-Inferiority Trial Evaluating Isavuconazole (ISA) vs. Voriconazole (VRC) for the Primary Treatment of Invasive Fungal Disease (IFD) Caused by Aspergillus spp. or other Filamentous Fungi (SECURE): Outcomes by Malignan (click for details)
ASP2397: A Novel Natural Product with Potent Fungicidal Activity against Aspergillus spp. (2)- In Vivo Activity against A. fumigatus (click for details)
Aspergillus PCR: Twenty Years In The Making, But Is It Enough To Make Prime Time? (click for details)
ASP2397: A Novel Natural Product with Potent Fungicidal Activity against Aspergillus spp. (1)-A New Mode of Action and In Vitro Activity (click for details)
Galactomannan Antigen Detection Immunoassay: an Intra-laboratory Reproducibility Study to Identify the Origin of Analytical False Positive Results (click for details)
Multilaboratory Testing of Two-Antifungal Drug Combinations Against Candida species and Aspergillus fumigates: Utility of 100% Inhibition as an End-point for Synergistic Measurement (click for details)
Host-Specific Production of Gliotoxin (GT) and Bis-methyl-gliotoxin (bmGT) During Invasive Aspergillosis (IA) (click for details)

Pages

Subscribe to ICAAC 54th (2014)